2018-07-17
New mechanism of Elafin to prevent lung injury in mechanically ventilated newborns
The Company's focus is on the development of anti-inflammatory treatments for rare diseases with significant unmet needs. Proteo is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases.
